Leuthold Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,837
Closed -$394K 232
2021
Q4
$394K Sell
3,837
-43
-1% -$4.13K 0.05% 155
2021
Q3
$339K Hold
3,880
0.04% 155
2021
Q2
$347K Sell
3,880
-105
-3% -$8.87K 0.04% 154
2021
Q1
$302K Sell
3,985
-100
-2% -$7.54K 0.04% 159
2020
Q4
$278K Sell
4,085
-164
-4% -$10.2K 0.04% 158
2020
Q3
$226K Sell
4,249
-118
-3% -$7.03K 0.03% 161
2020
Q2
$254K Buy
+4,367
New +$235K 0.04% 139
2019
Q4
Sell
-8,343
Closed -$444K 208
2019
Q3
$444K Sell
8,343
-428
-5% -$22K 0.06% 132
2019
Q2
$448K Sell
8,771
-1,583
-15% -$73.7K 0.06% 146
2019
Q1
$536K Sell
10,354
-587
-5% -$28.5K 0.07% 134
2018
Q4
$431K Buy
+10,941
New +$508K 0.06% 150

Other funds holding SYNH

Leuthold Group's SYNH Position: Q1 2022 in Review

Leuthold Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 3,837 shares — an estimated $394K sold.

Leuthold Group first reported a position in SYNH in Q4 2018 and held it in 11 quarters. The position peaked at $536K in Q1 2019. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • Leuthold Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Leuthold Group sold 3,837 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $394K.
  • Leuthold Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 11 quarters.
  • Leuthold Group's Syneos Health, Inc. Class A Common Stock position peaked at $536K in Q1 2019.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Leuthold Group's 13F filing for Q1 2022, filed 4 May 2022.